The study of proteins is transforming our understanding of human biology and disease, enabling breakthroughs in diagnostics, drug development, and advanced therapies. In this article, Mathias Uhlén, Professor of Microbiology at KTH Royal Institute of Technology and member of NorthX Biologics’ Board of Directors, explores:
- The Human Protein Atlas: A cornerstone for drug discovery and development.
- AI’s role in accelerating protein structure prediction and molecular interactions.
- Next-generation technologies revolutionizing diagnostics and therapeutic monitoring.
- NorthX Biologics’ innovation hub driving scalable, efficient protein production.
Join the journey into the future of protein science and learn how these advancements are shaping the next generation of precision medicine and therapeutic development.